Balancing Benefits and Harms on the Frontier of Buprenorphine Initiation

Ann Emerg Med. 2019 Sep;74(3):433-435. doi: 10.1016/j.annemergmed.2019.04.024. Epub 2019 Jun 20.

Authors

Reuben J Strayer¹, Andrew A Herring², Lewis S Nelson³

Affiliations

¹ Department of Emergency Medicine, Maimonides Medical Center, Brooklyn, NY. Electronic address: RStrayer@maimonidesmed.org.
² Department of Emergency Medicine and Substance Use Disorder Program, Highland Hospital-Alameda Health System, University of California, San Francisco, CA.
³ Department of Emergency Medicine and Division of Medical Toxicology, Rutgers New Jersey Medical School, Newark, NJ.

PMID: 31229393
DOI: 10.1016/j.annemergmed.2019.04.024

No abstract available

Publication types

Editorial
Comment

MeSH terms

Analgesics, Opioid
Buprenorphine*
Humans
Naloxone
Opioid-Related Disorders*

Substances

Analgesics, Opioid
Naloxone
Buprenorphine